Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden · Delayed Price · Currency is SEK 10.00
-0.06 (-0.60%)
Mar 2, 2026, 5:24 PM CET
Vicore Pharma Holding AB Market Cap
Vicore Pharma Holding AB has a market cap or net worth of 2.82 billion as of March 2, 2026. Its market cap has increased by 40.37% in one year.
Market Cap
2.82B
Enterprise Value
1.65B
Revenue
3.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.00
Market Cap Chart
Since December 10, 2015, Vicore Pharma Holding AB's market cap has increased from 87.82M to 2.82B, an increase of 3,105.84%. That is a compound annual growth rate of 40.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.83B | -10.97% |
| Dec 30, 2025 | 3.18B | 60.49% |
| Dec 30, 2024 | 1.98B | 25.12% |
| Dec 29, 2023 | 1.58B | 8.13% |
| Dec 30, 2022 | 1.47B | 46.67% |
| Dec 30, 2021 | 998.90M | -47.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.44B |
| Flerie AB | 2.85B |
| Saniona AB | 2.57B |
| Diamyd Medical AB | 2.04B |
| Egetis Therapeutics AB | 1.81B |
| BioInvent International AB | 1.53B |
| Cantargia AB | 1.18B |
| Genovis AB (publ.) | 1.14B |